Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma
MB Afonso, PM Rodrigues, AL Simao… - Journal of clinical …, 2016 - mdpi.com
Obesity and metabolic syndrome are growing epidemics worldwide and greatly responsible
for many liver diseases, including nonalcoholic fatty liver disease (NAFLD). NAFLD often …
for many liver diseases, including nonalcoholic fatty liver disease (NAFLD). NAFLD often …
MicroRNA‐190b regulates lipid metabolism and insulin sensitivity by targeting IGF‐1 and ADAMTS9 in non‐alcoholic fatty liver disease
M Xu, XM Zheng, F Jiang, W Qiu - Journal of cellular …, 2018 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is characterized by ectopic lipid accumulation and
insulin resistance, yet the underlying molecular mechanisms are poorly understood. MiR …
insulin resistance, yet the underlying molecular mechanisms are poorly understood. MiR …